Latest & greatest articles for irritable bowel syndrome

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on irritable bowel syndrome or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on irritable bowel syndrome and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for irritable bowel syndrome

141. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: a randomised controlled trial

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: a randomised controlled trial Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: a randomised controlled trial Journals Library An error has occurred in processing the XML document An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested (...) could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} The trial found that specially trained practice nurses can provide effective cognitive behavioural therapy (CBT) to primary care patients with a clinical diagnosis of irritable bowel syndrome, however CBT does not reduce service or social costs. It was also found

2006 NIHR HTA programme

142. The efficacy of antidepressants and various psychotherapies as adjunctive treatments for irritable bowel syndrome (IBS).

The efficacy of antidepressants and various psychotherapies as adjunctive treatments for irritable bowel syndrome (IBS). Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here

2006 University of Texas at Austin School of Nursing, Family Nurse Practitioner Program

143. Herbal medicines for treatment of irritable bowel syndrome. (PubMed)

Herbal medicines for treatment of irritable bowel syndrome. Traditional herbal therapies have been used for a long time to treat gastrointestinal disorders including irritable bowel syndrome, and their effectiveness from clinical research evidence needs to be systematically reviewed.To assess the effectiveness and safety of herbal medicines in patients with irritable bowel syndrome.We searched the following electronic databases till July 2004: The Cochrane Library (CENTRAL), MEDLINE, EMBASE (...) of randomised participants.Seventy-five randomised trials, involving 7957 participants with irritable bowel syndrome, met the inclusion criteria. The methodological quality of three double-blind, placebo-controlled trials was high, but the quality of remaining trials was generally low. Seventy-one different herbal medicines were tested in the included trials, in which herbal medicines were compared with placebo or conventional pharmacologic therapy. Herbal medicines were also combined with conventional

2006 Cochrane

144. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial

Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial Kennedy T M, Chalder T, McCrone P, Darnley S, Knapp M, Jones R H, Wessely S (...) Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Kennedy T M, Chalder T, McCrone P, Darnley S, Knapp M, Jones R H, Wessely S. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial. Health Technology Assessment 2006; 10(19): 1-84 Authors' objectives The aim

2006 Health Technology Assessment (HTA) Database.

145. Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review

Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review Effectiveness of the Chinese herbal formula TongXieYaoFang for irritable bowel syndrome: a systematic review Bian Z, Wu T, Liu L, Miao J, Wong H, Song L, Sung J J CRD summary The review assessed the Chinese herbal medicine TongXieYaoFang for irritable bowel syndrome. The authors (...) concluded that TongXieYaoFang together with other Chinese medicinal herbs has the potential to improve symptoms of irritable bowel syndrome more than conventional medicines. It is highly likely that the evidence reviewed was biased towards results in favour of TongXieYaoFang. Authors' objectives To evaluate the effectiveness of TongXieYaoFang (TXYF) with or without additional Chinese herbal medicines for the management of irritable bowel syndrome (IBS). Searching MEDLINE, EMBASE, the Cochrane Controlled

2006 DARE.

146. A self help guidebook reduced primary care consultations in irritable bowel syndrome

A self help guidebook reduced primary care consultations in irritable bowel syndrome A self help guidebook reduced primary care consultations in irritable bowel syndrome | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A self help guidebook reduced primary care consultations in irritable bowel syndrome Article Text Therapeutics A self help guidebook reduced primary care consultations in irritable bowel syndrome Statistics from

2006 Evidence-Based Medicine (Requires free registration)

147. Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome

Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

148. A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome

A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 NHS Economic Evaluation Database.

149. Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome

Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: soluble fibre improves overall symptoms and constipation but not abdominal pain in irritable bowel syndrome Article Text Therapeutics Review: soluble fibre

Full Text available with Trip Pro

2005 Evidence-Based Medicine (Requires free registration)

150. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. (PubMed)

Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. To assess the efficacy of cognitive behaviour therapy delivered in primary care for treating irritable bowel syndrome.Randomised controlled trial.10 general practices in London.149 patients with moderate or severe irritable bowel syndrome resistant to the antispasmodic mebeverine.Cognitive behaviour therapy delivered by trained primary care nurses plus (...) 270 mg mebeverine taken thrice daily compared with mebeverine treatment alone.Primary measures were patients' scores on the irritable bowel syndrome symptom severity scale. Secondary measures were scores on the work and social adjustment scale and the hospital anxiety and depression scale.Of 334 referred patients, 72 were randomised to mebeverine plus cognitive behaviour therapy and 77 to mebeverine alone. Cognitive behaviour therapy had considerable initial benefit on symptom severity compared

Full Text available with Trip Pro

2005 BMJ

151. Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action

Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action Tan G, Hammond D C, Gurrala J CRD summary This review concluded that variations on a protocol for hypnosis represent an effective therapy for reducing symptoms of irritable bowel syndrome and improving emotional and quality-of-life outcomes (...) in the long term. Several significant limitations in the review process, along with the paucity of the evidence reviewed, suggest that the authors' conclusions may be overstated and not particularly robust. Authors' objectives To assess the efficacy of hypnosis in reducing the symptoms and in improving emotional and quality-of-life outcomes associated with irritable bowel syndrome (IBS), and to examine the possible mechanisms of action. Searching The authors searched PubMed and PsycLIT, along with medical

2005 DARE.

152. Psychotherapy or paroxetine did not reduce abdominal pain, but may improve quality of life in irritable bowel syndrome

Psychotherapy or paroxetine did not reduce abdominal pain, but may improve quality of life in irritable bowel syndrome Psychotherapy or paroxetine did not reduce abdominal pain, but may improve quality of life in irritable bowel syndrome | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Psychotherapy or paroxetine did not reduce abdominal pain, but may improve quality of life in irritable bowel syndrome Article Text Economics

Full Text available with Trip Pro

2004 Evidence-Based Medicine (Requires free registration)

153. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. (PubMed)

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. Irritable bowel syndrome (IBS), which affects 11% to 14% of the population, is a puzzling condition with multiple models of pathophysiology including altered motility, visceral hypersensitivity, abnormal brain-gut interaction, autonomic dysfunction, and immune activation. Although no conceptual framework accounts for all the symptoms and observations in IBS, a unifying explanation may exist since 92 (...) between the pattern of bowel movement and the type of excreted gas, a prevalence of abnormal lactulose breath test in 84% of IBS patients, and a 75% improvement of IBS symptoms after eradication of SIBO. Altered gastrointestinal motility and sensation, changed activity of the central nervous system, and increased sympathetic drive and immune activation may be understood as consequences of the host response to SIBO.The gastrointestinal and immune effects of SIBO provide a possible unifying framework

Full Text available with Trip Pro

2004 JAMA

154. General practitioners' perceptions of chronic fatigue syndrome and beliefs about its management, compared with irritable bowel syndrome: qualitative study. (PubMed)

General practitioners' perceptions of chronic fatigue syndrome and beliefs about its management, compared with irritable bowel syndrome: qualitative study. To compare general practitioners' perceptions of chronic fatigue syndrome and irritable bowel syndrome and to consider the implications of their perceptions for treatment.Qualitative analysis of transcripts of group discussions.A randomly selected sample of 46 general practitioners in England.The participants tended to stereotype patients (...) participants would not consider referral for mental health interventions, even though the doctors recognised social and psychological factors, because they were not familiar with the interventions or thought them unavailable or unnecessary.Barriers to the effective clinical management of patients with irritable bowel syndrome and chronic fatigue syndrome are partly due to doctors' beliefs, which result in negative stereotyping of patients with chronic fatigue syndrome and the use of management strategies

Full Text available with Trip Pro

2004 BMJ

155. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis

Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis Spiegel B M R, DeRosa V P, Gralnek I M, Wang V, Dulai G S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion (...) on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two strategies for the management of patients with who met the Rome II criteria for diarrhoea-predominant irritable bowel syndrome (IBS-D) were compared. The first was the direct initiation of empirical IBS treatment. The second was initial screening for coeliac sprue (CS). In the second

2004 NHS Economic Evaluation Database.

156. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis

Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis Mein S M, Ladabaum U Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) with symptoms consistent with a diagnosis of IBS (irritable bowel syndrome) at acceptable cost per case detected and per QALY (quality-adjusted life-year) gained". Up-front oesophago-gastroduedenoscopy (EGD) plus biopsy in all patients with symptoms of IBS was always dominated by serological testing. CRD COMMENTARY - Selection of comparators The authors did not justify their choice of the comparators. However, no testing for coeliac disease in patients with suspected IBS would seem to represent the standard

Full Text available with Trip Pro

2004 NHS Economic Evaluation Database.

157. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis

Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2004 DARE.

158. A systematic review of alternative therapies in the irritable bowel syndrome

A systematic review of alternative therapies in the irritable bowel syndrome A systematic review of alternative therapies in the irritable bowel syndrome A systematic review of alternative therapies in the irritable bowel syndrome Spanier J A, Howden C W, Jones M P CRD summary This review concluded that there is no strong evidence for the effectiveness of alternative therapies in the treatment of irritable bowel syndrome. This was a poorly conducted review and it is unlikely that the findings (...) are reliable. Authors' objectives To review the available literature on alternative or complementary treatments for irritable bowel syndrome (IBS). Searching MEDLINE was searched from 1966 to 2001 for full papers in the English language. The bibliographies of included studies were also checked. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were eligible for inclusion. Some of the included studies were uncontrolled studies. Specific interventions

2003 DARE.

159. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials Cremonini F, Delgado-Aros S, Camilleri M CRD summary This review analysed six trials on the effects of alosetron in irritable bowel syndrome (IBS). The authors concluded that alosetron can improve (...) symptoms or decrease pain in female IBS patients without constipation. However, they also concluded that alosetron can have adverse effects, particularly constipation. The effects in men are unclear. These conclusions are appropriate given the evidence available. Authors' objectives To determine the effect of alosetron therapy on adequate relief of pain or global improvement of symptoms in patients with irritable bowel syndrome (IBS). Searching MEDLINE (from 1966 to 2002) and EMBASE (from 1988 to 2002

2003 DARE.

160. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2003 NHS Economic Evaluation Database.